Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.45 |
| ▸ | IRAK4 | Q9NWZ3 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | TLR2 | O60603 | 1/20 | 0.37 |
| ▸ | ERN1 | O75460 | 1/20 | 0.37 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.37 |
| ▸ | TLR6 | Q9Y2C9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4541926 | 0.92 | CYP1A2 (0.54) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL17662362 | 0.88 | MAPT (0.54) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL30092827 | 0.88 | MAPT (0.54) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL4540583 | 0.87 | CYP1A2 (0.53) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL1427814 | 0.84 | MAPT (0.50) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL677274 | 0.80 | MCHR1 (0.46) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL21850064 | 0.79 | CYP1A2 (0.46) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL11212238 | 0.78 | CYP1A2 (0.44) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL24026496 | 0.77 | CYP1A2 (0.41) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 | |
| SCHEMBL19583184 | 0.77 | CYP1A2 (0.41) | CYP1A2MAPTCYP2C9CYP2C19ALDH1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120209007-A9 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-08-16 | — | — | US | disclosed |
| US-20110319629-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2011-12-29 | — | — | US | disclosed |
| EP-2396289-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | Agency For Science, Technology And Research (SG) | 2011-12-21 | — | — | EP | disclosed |
| US-20100249443-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-09-30 | — | — | US | disclosed |
| WO-2010093336-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-08-19 | — | — | WO | disclosed |
| WO-2010093327-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-08-19 | — | — | WO | disclosed |
| US-20100185000-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-22 | — | — | US | disclosed |
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2010-07-15 | — | — | US | disclosed |
| US-7732544-B2 | Titanium compound and process for producing optically active cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2010-06-08 | — | — | US | disclosed |
| EP-2190851-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | Agency for Science, Technology and Research (SG) | 2010-06-02 | — | — | EP | disclosed |
| WO-2009041919-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2009-04-02 | — | — | WO | disclosed |
| WO-2008121074-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | disclosed |
| WO-2008121076-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2008-10-09 | — | — | WO | disclosed |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | MITSUI CHEMICALS, INC. (JP) | 2007-11-15 | — | — | US | disclosed |
| EP-1806336-A1 | TITANIUM COMPOUND AND METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRINS | Mitsui Chemicals, Inc. (JP) | 2007-07-11 | — | — | EP | disclosed |
| US-6977315-B2 | by nitroaldol reactions of aldehydes using an asymmetric catalyst; beta -nitroalcohols are important intermediates of optically active aminoalcohols which are useful as starting materials in synthesizing fine chemicals and drugs | MITSUI CHEMICALS, INC. (JP) | 2005-12-20 | — | — | US | disclosed |
| US-20050215832-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE NITROALCOHOLS | MITSUI CHEMICALS, INC. (JP) | 2005-09-29 | — | — | US | disclosed |
| EP-0210140-B1 | INHIBITORS OF BENZYLAMINOXIDASES, SELECTIVE WITH RESPECT TO OTHER AMINOXIDASES | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1990-06-13 | — | — | EP | disclosed |
| US-4888283-A | Selective inhibitors of benzylaminoxidases with respect to other aminoxidases | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1989-12-19 | — | — | US | disclosed |
| EP-0210140-A2 | Inhibitors of benzylaminoxidases, selective with respect to other aminoxidases | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 1987-01-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100179343-A1 | METHOD OF PRODUCING AN OPTICALLY ACTIVE CYANOHYDRIN DERIVATIVE | TDO2, AOX1, DAO | CYP1A2 1806/4885MAPT 4873/4885CYP2C9 2086/4885 |
| US-20100185000-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | ABL1, CD59, TDO2 | CYP1A2 474/4885MAPT 3880/4885CYP2C9 977/4885 |
| US-20070265463-A1 | Titanium Compound and Process for Producing Optically Active Cyanohydrins | WNT1, C3AR1, TDO2 | CYP1A2 776/4885MAPT 4693/4885CYP2C9 1161/4885 |
| US-20050215832-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE NITROALCOHOLS | CBR1, CBR3, NQO1 | CYP1A2 152/4885MAPT 4481/4885CYP2C9 905/4885 |
| US-20110319629-A1 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | ABL1, TYR, CD59 | CYP1A2 487/4885MAPT 3932/4885CYP2C9 635/4885 |
| US-20100249443-A1 | TITANIUM COMPOUND AND PROCESS FOR ASYMMETRIC CYANATION OF IMINES | ABL1, CD59, TDO2 | CYP1A2 474/4885MAPT 3880/4885CYP2C9 977/4885 |
| US-20120209007-A9 | TITANIUM COMPOUNDS AND PROCESS FOR CYANATION OF IMINES | ABL1, TYR, CD59 | CYP1A2 487/4885MAPT 3932/4885CYP2C9 635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.